Rochester General Hospital continues to lead the way in women’s healthcare by offering the latest FDA-approved technology to screen women who have dense breast tissue. It’s estimated that upwards of 50 percent of women have that condition which makes detecting small cancers more difficult during routine mammography.
“The Automated Breast Ultrasound System (ABUS) at Rochester General Hospital is now being used to screen asymptomatic women with dense breast tissue and no prior interventions,” said William Bowen MD, MS, Chief of Women’s Imaging for Rochester Regional Health System. “Research shows that ABUS technology used along with mammography has the potential to find more than 35 percent additional cancers that would not have been detected using mammography alone.”
In January of 2013, New York State began requiring that physicians notify women whose mammography indicates they have dense breast tissue – a condition that Dr. Bowen says is more common in younger women.
It is known, according to multiple large studies, that dense breast tissue -- by itself, independent of other risk factors -- can increase the risk of developing breast cancer. Moreover, a study in the New England Journal of Medicine shows that dense breast tissue can mask the appearance of tumors.
For more information about ABUS, and to schedule an appointment, please call (585) 922-XRAY (9729)
Monday, November 5, 2018
The College of Healthcare Information Management Executives (CHIME) has named Rochester Regional Health one of Healthcare’s Most Wired for 2018. The distinction is based on the system’s ability to adopt, implement and apply new information technology to improve healthcare outcomes.Read News Article
Friday, October 26, 2018
Meet Nicole Snyder: a mother, a wife, and a breast cancer survivor. Her diligence about routine breast screening may have saved her life.Read News Article